JP2021176829A5 - - Google Patents

Download PDF

Info

Publication number
JP2021176829A5
JP2021176829A5 JP2020119469A JP2020119469A JP2021176829A5 JP 2021176829 A5 JP2021176829 A5 JP 2021176829A5 JP 2020119469 A JP2020119469 A JP 2020119469A JP 2020119469 A JP2020119469 A JP 2020119469A JP 2021176829 A5 JP2021176829 A5 JP 2021176829A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
set forth
acid sequences
sequence identity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020119469A
Other languages
English (en)
Japanese (ja)
Other versions
JP7572668B2 (ja
JP2021176829A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2021176829A publication Critical patent/JP2021176829A/ja
Publication of JP2021176829A5 publication Critical patent/JP2021176829A5/ja
Priority to JP2024173323A priority Critical patent/JP2025004094A/ja
Application granted granted Critical
Publication of JP7572668B2 publication Critical patent/JP7572668B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020119469A 2019-07-12 2020-07-10 歯の再生治療のためのｕｓａｇ－１を標的分子とした中和抗体 Active JP7572668B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024173323A JP2025004094A (ja) 2019-07-12 2024-10-02 歯の再生治療のためのｕｓａｇ－１を標的分子とした中和抗体

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2019130153 2019-07-12
JP2019130153 2019-07-12
JP2020080723 2020-04-30
JP2020080723 2020-04-30

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024173323A Division JP2025004094A (ja) 2019-07-12 2024-10-02 歯の再生治療のためのｕｓａｇ－１を標的分子とした中和抗体

Publications (3)

Publication Number Publication Date
JP2021176829A JP2021176829A (ja) 2021-11-11
JP2021176829A5 true JP2021176829A5 (https=) 2023-06-14
JP7572668B2 JP7572668B2 (ja) 2024-10-24

Family

ID=74209883

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020119469A Active JP7572668B2 (ja) 2019-07-12 2020-07-10 歯の再生治療のためのｕｓａｇ－１を標的分子とした中和抗体
JP2024173323A Pending JP2025004094A (ja) 2019-07-12 2024-10-02 歯の再生治療のためのｕｓａｇ－１を標的分子とした中和抗体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024173323A Pending JP2025004094A (ja) 2019-07-12 2024-10-02 歯の再生治療のためのｕｓａｇ－１を標的分子とした中和抗体

Country Status (6)

Country Link
US (1) US20220259298A1 (https=)
EP (1) EP4000633A4 (https=)
JP (2) JP7572668B2 (https=)
KR (1) KR20220034176A (https=)
CN (2) CN114364694B (https=)
WO (1) WO2021010346A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4115889A4 (en) * 2020-02-21 2024-10-02 Kyoto University Medicine containing usag-1-targeting rna molecule for tooth regeneration therapy
EP4474394A4 (en) * 2022-02-03 2026-04-15 Univ Kyoto Neutralizing antibody targeting a molecule called USAG-1 for treating tooth regeneration
CN116425870A (zh) * 2023-05-24 2023-07-14 陕西师范大学 一种抗新型冠状病毒n蛋白单克隆抗体31a8及其产品和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999000405A1 (en) * 1997-06-30 1999-01-07 Genetics Institute, Inc. Secreted proteins
US20040023356A1 (en) * 2002-06-14 2004-02-05 Robb Krumlauf Wise/Sost nucleic acid sequences and amino acid sequences
CN1618807A (zh) * 2003-11-21 2005-05-25 上海人类基因组研究中心 分泌蛋白及其编码序列和用途
CN1842540B (zh) * 2004-07-09 2012-07-04 中外制药株式会社 抗-磷脂酰肌醇蛋白聚糖3抗体
WO2009131553A2 (en) 2006-12-29 2009-10-29 Osteogenex Inc. Methods of altering bone growth by administration of sost or wise antagonist or agonist
TWI489993B (zh) 2007-10-12 2015-07-01 Novartis Ag 骨硬化素（ｓｃｌｅｒｏｓｔｉｎ）抗體組合物及使用方法
CN101925611A (zh) * 2007-11-21 2010-12-22 安姆根有限公司 Wise结合剂和表位
GB0911060D0 (en) 2009-06-26 2009-08-12 Ge Healthcare Uk Ltd Methods for predicting the toxicity of a chemical
WO2011075636A2 (en) * 2009-12-18 2011-06-23 Amgen Inc. Wise binding agents and epitopes
KR102155531B1 (ko) * 2012-03-30 2020-09-15 도레이 카부시키가이샤 간암의 치료 및/또는 예방용 의약 조성물
WO2015120138A2 (en) * 2014-02-05 2015-08-13 Dana-Farber Cancer Institute, Inc. AGENTS THAT MODULATE RGMb-NEOGENIN-BMP SIGNALING AND METHODS OF USE THEREOF
KR102876923B1 (ko) * 2015-10-23 2025-10-28 화이자 인코포레이티드 항-il-2 항체 및 조성물 및 이의 용도
KR20190044070A (ko) * 2016-08-03 2019-04-29 넥스트큐어 인코포레이티드 Lair 신호 변환을 조정하기 위한 조성물 및 방법

Similar Documents

Publication Publication Date Title
JP2022177090A5 (https=)
JP2021502984A5 (https=)
JP2015504421A5 (https=)
JP2018517431A5 (https=)
RU2016100892A (ru) Антитела против tweakr и их применение
JP2019535763A5 (https=)
RU2019118359A (ru) Антитело к cd73 человека
RU2016129274A (ru) Канинизированные мышиные антитела к человеческому pd-1
RU2011105062A (ru) Нейтрализующие антитела против вируса гриппа а и их использование
JP2023071956A5 (https=)
RU2014122990A (ru) Способы комбинированной терапии с применением молекул, связывающихся с psl и pcrv pseudomonas
RU2018133708A (ru) Антитела, обладающие специфичностью к btla, и их использование
RU2014108047A (ru) Фармацевтическая композиция для лечения и/или профилактики рака поджелудочной железы
RU2016137110A (ru) Антитела к компоненту комплемента с5
RU2021129189A (ru) Антитела против фактора свертывания xi
RU2009129403A (ru) Антитела, нейтрализующие цитомегаловирус человека, и их применение
JP2021176829A5 (https=)
RU2018102606A (ru) Молекулы, связывающиеся с psl pseudomonas, и пути их применения
JP2016530223A5 (https=)
JPWO2020059847A5 (https=)
JP2017504321A5 (https=)
RU2017139800A (ru) Комбинированный препарат антител против staphylococcus aureus
JP2016520313A5 (https=)
JP2021511387A5 (https=)
JP2022500455A5 (https=)